Bladder Cancer
Bladder cancer, specifically urothelial carcinoma, is a type of cancer that begins in the cells lining the bladder and can cause symptoms such as blood in urine, frequent urination, and pelvic pain.
Bladder Cancer: Pembrolizumab and Enfortumab Combination
We are studying a combination of two medications for patients with first-line metastatic urothelial carcinoma. The aim is to evaluate their safety and effectiveness in treating this advanced cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
service d'oncologie Medicale
Bordeaux, France
Assistance Publique Hopitaux De Paris
service de cancerologie
Issy-les-Moulineaux, France
Centre Hospitalier Lyon Sud
service d'oncologie Medicale
Oullins, France
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.